Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Herman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 15, 2004
Lamotrigine: a depression mood stabiliserErik Herman
Epilepsy & Behavior : E&B|May 10, 2003
Treatment of Interictal Depression with Citalopram in Patients with EpilepsyJiri Hovorka, Erik Herman, Iveta Nemcová
Neuro Endocrinology Letters|January 4, 2011
Is pseudo-intractability in population of patients with epilepsy still alive in the 21st century? Audit of 100 seizure-free patients, referred with the diagnosis of pharmacoresistant epilepsyMichal Bajacek, Jiri Hovorka, Tomas Nezadal, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|March 6, 2008
Psychogenic non-epileptic seizures, prospective clinical experience: diagnosis, clinical features, risk factors, psychiatric comorbidity, treatment outcomeJirí Hovorka, Tomás Nezádal, Erik Herman, et al.
Neurological Research|July 16, 2011
Psychogenic non-epileptic seizures: our video-EEG experienceTomáš Nežádal, Jiří Hovorka, Erik Herman, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 9, 2007
A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) studyRobert Kerwin, Bruno Millet, Erik Herman, et al.
International Clinical Psychopharmacology|January 24, 2020
A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorderAndrea Fagiolini, Umberto Albert, Laura Ferrando, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 15, 2004
Lamotrigine: a depression mood stabiliserErik Herman
Epilepsy & Behavior : E&B|May 10, 2003
Treatment of Interictal Depression with Citalopram in Patients with EpilepsyJiri Hovorka, Erik Herman, Iveta Nemcová
Neuro Endocrinology Letters|January 4, 2011
Is pseudo-intractability in population of patients with epilepsy still alive in the 21st century? Audit of 100 seizure-free patients, referred with the diagnosis of pharmacoresistant epilepsyMichal Bajacek, Jiri Hovorka, Tomas Nezadal, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|March 6, 2008
Psychogenic non-epileptic seizures, prospective clinical experience: diagnosis, clinical features, risk factors, psychiatric comorbidity, treatment outcomeJirí Hovorka, Tomás Nezádal, Erik Herman, et al.
Neurological Research|July 16, 2011
Psychogenic non-epileptic seizures: our video-EEG experienceTomáš Nežádal, Jiří Hovorka, Erik Herman, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 9, 2007
A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) studyRobert Kerwin, Bruno Millet, Erik Herman, et al.
International Clinical Psychopharmacology|January 24, 2020
A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorderAndrea Fagiolini, Umberto Albert, Laura Ferrando, et al.
Pageof 1